Event-free survival at 24 months captures central nervous system relapse of systemic diffuse large B-cell lymphoma in the immunochemotherapy era.

Authors :: Thanarajasingam G
Maurer MJ
Farooq U
Johnston PB
Thompson CA
Bennani NN
Ansell SM
Porrata LF
Macon WR
Syrbu SI
Cerhan JR
Habermann TM
Link BK
Witzig TE
Nowakowski GS
Source :: British journal of haematology [Br J Haematol] 2018 Oct; Vol. 183 (1), pp. 149-152. Date of Electronic Publication: 2017 Sep 29.
Publication Year :: 2018

Subjects :: Adolescent
Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Central Nervous System Neoplasms etiology
Female
Follow-Up Studies
Humans
Immunotherapy, Adoptive methods
Lymphoma, Large B-Cell, Diffuse complications
Lymphoma, Large B-Cell, Diffuse pathology
Male
Middle Aged
Progression-Free Survival
Recurrence
Young Adult
Central Nervous System Neoplasms therapy
Lymphoma, Large B-Cell, Diffuse therapy

Full Text Access

Tools